To participate, you must be a current medical student, resident, or have graduated within the past 2 years, U.S. based.
I’m writing a reported article for Medscape on how medical students, residents, and recent grads respond to moments when professionalism falters in clinical settings—especially those “wait, is this okay?” gray-area situations.
I’m looking for people willing to share on the record about:
An instance when you observed behavior that felt unprofessional (from a peer, resident, or attending)
Whether you spoke up or reported it, and what happened next
How your training did—or didn’t—prepare you for this kind of ethical uncertainty
What advice you’d offer someone facing a similar moment
Important:
To participate, you must be a current medical student, resident, or have graduated within the past 2 years.
All contributions must be attributed by name, and responses may be quoted in the published piece on Medscape.
Your full name and preferred credentials (e.g., Jane Smith, MD, or Jane Smith, MS4) *credentials will be verified*
Your current role/school/residency program
Confirmation that Medscape has your permission to publish your responses with attribution
posted6/4/2025
deadline6/6/2025
processing
published
Recently published by Medscape
Looking to speak with Ob-Gyns, Maternal-Fetal and primary care experts
Seeking U.S.-based experts in pulmonology to comment on innovations in COPD and asthma care
I am working on a Medscape article about new approaches to managing COPD and asthma that go beyond standard inhaler therapy. I am seeking U.S.-based pulmonologists, researchers, or physicians with experience in pulmonary medicine to share insights on emerging strategies in clinical practice and research.
Questions:
What innovations in COPD and asthma care are you seeing beyond pharmacotherapy (e.g., breathing techniques, pulmonary rehab, personalized approaches)?
Are you using or researching personalized oxygen protocols? If so, how do they compare with standard oxygen therapy?
What role do biologic or precision-medicine therapies play in COPD and asthma management today?
What barriers exist in implementing these newer approaches (cost, access, adherence)?
How can primary care providers best incorporate or refer for these innovations?
Looking ahead, what developments are most promising for improving COPD and asthma outcomes over the next 5 years?
Consent Note:
By responding, you consent to being quoted in a Medscape article with attribution. Quotes may be lightly edited for clarity, style, and flow. Please disclose any potential conflicts of interest (such as financial relationships with relevant companies or organizations).